Read + Share
Amedeo Smart
Independent Medical Education
Suraya R, Nagano T, Ryanto GRT, Effendi WI, et al. Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation. Respir Res 2022;23:173.PMID: 35761394
Email
LinkedIn
Facebook
Twitter
Privacy Policy